KTTAW vs MTD
Pasithea Therapeutics Corp. Warrant (KTTAW) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
KTTAW does not have a complete income-statement cache yet.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
KTTAW currently screens at market cap $0. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the KTTAW and MTD stock pages for the full models.
Not investment advice.